Category: Hypersomnias

Hypersomnias

Pitolisant Trial for Idiopathic Hypersomnia Ahead of Schedule

Harmony Biosciences announced an accelerated timeline for completing its phase 3 study evaluating pitolisant in adults idiopathic hypersomnia.

Hypersomnias

Harmony Biosciences Provides 2022 Business Updates

Harmony Biosciences spelled out next steps in its pursuit of pediatric exclusivity for WAKIX.

Hypersomnias

What’s Sex Got to Do with Narcolepsy?

New mouse studies suggest potential sex and gender differences in narcolepsy symptoms, but will the dissimilarities extend to humans?

Narcolepsy

Tris Pharma Is Working on a Low Sodium, Once-Nightly Oxybate Formulation for Narcolepsy

Tris has developed an oxybate formulation intended for the treatment of cataplexy or excessive daytime sleepiness in people with narcolepsy.

Idiopathic Hypersomnia

Jazz Pharmaceuticals Gets Development Rights to Orexin-2 Receptor Agonist with Treatment Potential for Narcolepsy, IH, and More

Jazz Pharmaceuticals has acquired development and commercialization rights in the United States for Sumitomo's investigational DSP-0187.

Insufficient Sleep Syndrome

Sleep Disorders and Lack of Sleep Plague Active US Military Personnel

A new study found that 85% of active duty servicemen and servicewomen have sleep disorders.

When Seizures Strike Sleep

Kleine-Levin Syndrome

AASM Updates Guidance on the Treatment of Narcolepsy & Other Hypersomnias

A new American Academy of Sleep Medicine clinical practice guideline details “strong” and “conditional” recommendations for the treatment of central disorders of hypersomnolence in adults and children.